Insulin resistance and in-stent restenosis: could modulating insulin improve outcomes of percutaneous coronary intervention?

被引：2
|
作者：
Armstrong, Ehrin J. [1 ]
McCabe, James M. [2 ]
机构：
[1] Univ Colorado, Sch Med, Dept Med, VA Eastern Colorado Healthcare Syst,Div Cardiol, Denver, CO 80220 USA
[2] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA
来源：
CORONARY ARTERY DISEASE | 2015年 / 26卷 / 01期
关键词：
DIABETES-MELLITUS; GLYCEMIC CONTROL; IMPLANTATION; REVASCULARIZATION; HEMOGLOBIN; GLUCOSE; EVENTS;
D O I：
10.1097/MCA.0000000000000185
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [41] Risk factors associated with intra-stent restenosis after percutaneous coronary intervention
    Alexandrescu, Dan-Mihai
    Mitu, Ovidiu
    Costache, Irina Iuliana
    Macovei, Liviu
    Mitu, Ivona
    Alexandrescu, Anca
    Georgescu, Catalina Arsenescu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [42] Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent
    Ichimoto, Eiji
    Kadohira, Tadayuki
    Nakayama, Takashi
    De Gregorio, Joseph
    INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 14 - 20
  • [43] Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients
    Nishimura, Masato
    Tokoro, Toshiko
    Nishida, Masasya
    Hashimoto, Tetsuya
    Kobayashi, Hiroyuki
    Yamazaki, Satoru
    Imai, Ryo
    Okino, Koji
    Takahashi, Hakuo
    Ono, Toshihiko
    NEPHRON CLINICAL PRACTICE, 2008, 109 (01): : C9 - C17
  • [44] Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
    Wanha, Wojciech
    Bil, Jacek
    Kolodziejczak, Michalina
    Kowalowka, Adam
    Kowalewski, Mariusz
    Hudziak, Damian
    Gocol, Radoslaw
    Januszek, Rafal
    Figatowski, Tomasz
    Milewski, Marek
    Tomasiewicz, Brunon
    Kuebler, Piotr
    Hrymniak, Bruno
    Desperak, Piotr
    Kuzma, Lukasz
    Milewski, Krzysztof
    Gora, Bartlomiej
    Los, Andrzej
    Kulczycki, Jan
    Wlodarczak, Adrian
    Skorupski, Wojciech
    Grygier, Marek
    Lesiak, Maciej
    D'Ascenzo, Fabrizio
    Andres, Marek
    Kleczynski, Pawel
    Litwinowicz, Radoslaw
    Borin, Andrea
    Smolka, Grzegorz
    Reczuch, Krzysztof
    Gruchala, Marcin
    Gil, Robert J.
    Jaguszewski, Milosz
    Bartus, Krzysztof
    Suwalski, Piotr
    Dobrzycki, Slawomir
    Dudek, Dariusz
    Bartus, Stanislaw
    Gasior, Mariusz
    Ochala, Andrzej
    Lansky, Alexandra J.
    Deja, Marek
    Legutko, Jacek
    Kedhi, Elvin
    Wojakowski, Wojciech
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [45] Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
    Lin, Xiao Long
    Li, Qiu Yu
    Zhao, Dong Hui
    Liu, Jing Hua
    Fan, Qian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [46] Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes
    Abreu Marino, Barbara Campos
    Nascimento, Guilherme Abreu
    Rabelo, Walter
    Marino, Marcos Antonio
    Marino, Roberto Luiz
    Pinho Ribeiro, Antonio Luiz
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 104 (05) : 375 - 386
  • [47] Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study
    Natarajan, Madhu K.
    Strauss, Bradley H.
    Rokoss, Michael
    Buller, Christopher E.
    Mancini, G. B. John
    Xie, Changchun
    Sheth, Tej N.
    Goodhart, David
    Cohen, Eric A.
    Seidelin, Peter
    Harper, William
    Gerstein, Hertzel C.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (02) : 95 - 100
  • [48] Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis
    Aoyama, Yutaka
    Hirayama, Haruo
    Ishii, Hideki
    Kobayashi, Koichi
    Ishikawa, Kiyotake
    Takigawa, Masateru
    Nanasato, Mamoru
    Yoshida, Yukihiko
    Aoyama, Toru
    Yoshikawa, Daiji
    Matsubara, Tatsuaki
    Murohara, Toyoaki
    CORONARY ARTERY DISEASE, 2012, 23 (08) : 528 - 532
  • [49] Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome
    Liu, Chi
    Zhao, Qi
    Zhao, Ziwei
    Ma, Xiaoteng
    Xia, Yihua
    Sun, Yan
    Zhang, Dai
    Liu, Xiaoli
    Zhou, Yujie
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [50] Angiographic Characteristics of Femoropopliteal In-Stent Restenosis: Association with Long-Term Outcomes After Endovascular Intervention
    Armstrong, Ehrin J.
    Singh, Satinder
    Singh, Gagan D.
    Yeo, Khung-Keong
    Ludder, Shaan
    Westin, Gregory
    Anderson, David
    Dawson, David L.
    Pevec, William C.
    Laird, John R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (07) : 1168 - 1174
12345